BTK degraders tackle drug resistance
- PMID: 38336888
- DOI: 10.1038/d41573-024-00027-1
BTK degraders tackle drug resistance
Keywords: Biotechnology; Cancer; Chemical biology; Drug discovery; Therapeutics.
Comment on
-
Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127.Science. 2024 Feb 2;383(6682):eadi5798. doi: 10.1126/science.adi5798. Epub 2024 Feb 2. Science. 2024. PMID: 38301010 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
